MaxCyte Inc (MXCT) Stock Analysis

MaxCyte Inc (MXCT) is a publicly traded company in the HEALTHCARE sector. It trades at $1.33, carries a market capitalization of $137.12M. This page summarizes the public market data, fundamentals, and frequently asked questions for MXCT, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - MEDICAL DEVICES

Exchange: NASDAQ

Key Metrics

• Price: $1.33
• Market Cap: $137.12M
• EPS: $-0.36
• 52-Week High: $2.37
• 52-Week Low: $0.64

Market Sentiment

MaxCyte Inc currently has a Neutral sentiment score of 0.12.

About MaxCyte Inc

None

GNG Research Analysis

GNG Research scores MaxCyte Inc (MXCT) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for MXCT.

Frequently Asked Questions

Does MXCT pay dividends?

MaxCyte Inc (MXCT) does not currently pay a regular dividend.

What is MXCT's market cap?

MaxCyte Inc (MXCT) has a market capitalization of $137.12M with a current stock price of $1.33.